Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response
- PMID: 28468762
- DOI: 10.1136/gutjnl-2017-314263
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response
Keywords: NONALCOHOLIC STEATOHEPATITIS; PHARMACOTHERAPY.
Conflict of interest statement
Competing interests: AS: Consultant for Echosens-Sandhil and Sequana.
Comment on
-
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.Gut. 2017 Jan;66(1):180-190. doi: 10.1136/gutjnl-2016-312431. Epub 2016 Sep 19. Gut. 2017. PMID: 27646933 Review.
-
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus.Gut. 2018 Jul;67(7):1371. doi: 10.1136/gutjnl-2017-313958. Epub 2017 Apr 13. Gut. 2018. PMID: 28408383 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical